StayHappi Glibenclamide+Metformin 5mg/500mg Tablet

Name: StayHappi Glibenclamide+Metformin 5mg/500mg Tablet
Brand: Sarvagunaushdhi Pvt Ltd
Price: 15 INR

Prescription Required

Marketer

Sarvagunaushdhi Pvt Ltd

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview StayHappi Glibenclamide+Metformin 5mg/500mg Tablet

DiaBeta, a Glibenclamide/Metformin 5mg/500mg combination tablet, is an oral antidiabetic medication. This dual-action formulation manages type 2 diabetes in adults by regulating blood glucose. DiaBeta should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels; abrupt cessation can lead to dangerously elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, DiaBeta is one component of a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle adjustments are essential for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize these symptoms and carry a readily available source of fast-acting glucose, such as sugary snacks or juice. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. DiaBeta is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your physician.

Uses of StayHappi Glibenclamide+Metformin 5mg/500mg Tablet

Adult-onset diabetes

Major Benefits of StayHappi Glibenclamide+Metformin 5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The StayHappi Glibenclamide+Metformin 5mg/500mg Tablet should be administered with a meal.

Common Side effects of StayHappi Glibenclamide+Metformin 5mg/500mg Tablet:

Dizziness
Diarrhea
Nausea
Flatulence
Headache
Upper respiratory tract infection

How to use StayHappi Glibenclamide+Metformin 5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the StayHappi Glibenclamide+Metformin 5mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with meals.

How StayHappi Glibenclamide+Metformin 5mg/500mg Tablet works:

Glibenclamide, a sulfonylurea drug, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholUNSAFE

Consuming alcohol while taking StayHappi Glibenclamide+Metformin 5mg/500mg tablets is hazardous.

PregnancySAFE IF PRESCRIBED

The use of StayHappi Glibenclamide+Metformin 5mg/500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.

Breast feedingCAUTION

The use of StayHappi Glibenclamide+Metformin 5mg/500mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.

DrivingCONSULT YOUR DOCTOR

Driving ability while taking StayHappi Glibenclamide+Metformin 5mg/500mg Tablets is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyUNSAFE

The combination of glibenclamide and metformin (StayHappi 5mg/500mg) is likely unsuitable for individuals with impaired kidney function and should be avoided. Seek medical advice.

LiverCAUTION

Patients with liver impairment should exercise caution when using StayHappi Glibenclamide+Metformin 5mg/500mg tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take StayHappi Glibenclamide+Metformin 5mg/500mg Tablet :

Should you forget a dose of StayHappi Glibenclamide+Metformin 5mg/500mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About StayHappi Glibenclamide+Metformin 5mg/500mg Tablet

Label	Value
Developing Habits	No.
Treatment Category	Diabetes Treatment

FAQs on StayHappi Glibenclamide+Metformin 5mg/500mg Tablet

StayHappi Glibenclamide/Metformin 5mg/500mg tablets combine glibenclamide and metformin to manage type 2 diabetes. This combination improves blood sugar control in adults when used with diet and exercise. Glibenclamide stimulates insulin release, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.

Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize the insulin it does produce effectively. This leads to elevated blood glucose, causing various health issues. Symptoms of high blood sugar include excessive thirst, frequent urination, and increased hunger. Untreated, type 2 diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and an increased risk of heart disease.

StayHappi Glibenclamide+Metformin 5mg/500mg Tablets may cause common side effects such as hypoglycemia, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.

StayHappi Glibenclamide+Metformin 5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.

Prolonged use of StayHappi Glibenclamide+Metformin 5mg/500mg Tablets can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may manifest as anemia, nerve damage (including tingling, numbness in extremities, and weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.

StayHappi Glibenclamide+Metformin 5mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, those with moderate to severe kidney disease, and those experiencing metabolic acidosis, including diabetic ketoacidosis.

Combining StayHappi Glibenclamide+Metformin 5mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.

StayHappi Glibenclamide/Metformin 5mg/500mg tablets combine glibenclamide and metformin to manage type 2 diabetes. This combination improves blood glucose control in adults, alongside diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.

Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize existing insulin effectively. This leads to elevated blood glucose, causing various health issues. High blood sugar symptoms include excessive urination, thirst, and hunger. Untreated, type 2 diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and increased risk of heart disease.

StayHappi Glibenclamide+Metformin 5mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Long-term use may also result in vitamin B12 deficiency.

StayHappi Glibenclamide+Metformin 5mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.

Prolonged use of StayHappi Glibenclamide+Metformin 5mg/500mg Tablets can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may manifest as anemia, nerve damage (including tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.

StayHappi Glibenclamide+Metformin 5mg/500mg Tablets are contraindicated in patients allergic to any ingredient or excipient. They should not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.

Combining StayHappi Glibenclamide+Metformin 5mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.

MRP 17

11% off

Inclusive of all taxes

Quantity:

of Tablet

StayHappi Glibenclamide+M...